当前位置: X-MOL 学术Cancer Discov. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
In This Issue.
Cancer Discovery ( IF 28.2 ) Pub Date : 2020-01-01 , DOI: 10.1158/2159-8290.cd-iti10-1
American Association for Cancer Research

See article, [p. 40][1]
![][2] Triggering adenosine 2A receptors (A2AR) on the cell surface can suppress the antitumor effects of various immune cells, making A2AR signaling a potentially useful immunotherapy target. Fong and colleagues conducted a phase I clinical trial of the


中文翻译:

在这个问题上。

参见文章[p。40] [1]
![] [2]触发细胞表面的腺苷2A受体(A2AR)可以抑制各种免疫细胞的抗肿瘤作用,从而使A2AR信号传导成为潜在有用的免疫治疗靶点。方和同事进行了I期临床试验
更新日期:2020-04-21
down
wechat
bug